Skip to main content
AMARIN CORP PLC\UK logo

AMARIN CORP PLC\UK — Investor Relations & Filings

Ticker · AMRN ISIN · US0231114044 US Manufacturing
Filings indexed 1,173 across all filing types
Latest filing 2026-01-06 Director's Dealing
Country US United States of America
Listing US AMRN

About AMARIN CORP PLC\UK

https://amarincorp.com/

Amarin Corporation plc is a pharmaceutical company focused on the development and commercialization of therapeutics to improve cardiovascular health. The company's primary mission is to address the persistent cardiovascular risk that remains for many patients despite standard therapies. Its lead product, Vascepa (icosapent ethyl), is a prescription-grade omega-3 fatty acid used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and to reduce the risk of cardiovascular events in certain high-risk patient groups. Amarin is dedicated to creating a new paradigm in cardiovascular disease management to help prevent heart attacks and strokes for patients worldwide.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2026-01-06 English
4 Filing
Director's Dealing
2026-01-06 English
4 Filing
Director's Dealing
2026-01-06 English
4 Filing
Director's Dealing
2026-01-06 English
3
Director's Dealing
2025-10-31 English
10-Q
Interim / Quarterly Report Q3 2025
2025-10-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.